| Type of Material: | Thesis |
| Title: | Nanocarrier mediated Tumor specific Co-delivery of dual-action Cisplatin (IV) prodrug and venetoclax for improved Therapeutic outcomes in triple negative Breast Cancer treatment |
| Researcher: | Date, Tushar Dilip |
| Guide: | Jain, Sanyog |
| Department: | Department of Pharmaceutics |
| Publisher: | Saurashtra University, Rajkot |
| Place: | Mohali |
| Year: | 2022 |
| Language: | English |
| Subject: | Nanocarrier mediated | Tumor | Cisplatin (IV) prodrug | Therapeutic outcomes | Breast Cancer treatment |
| Dissertation/Thesis Note: | PhD |
| 000 | 00000ntm a2200000ua 4500 | |
| 001 | 445043 | |
| 003 | IN-AhILN | |
| 005 | 2022-09-12 15:25:34 | |
| 008 | __ | 220912t2022||||ii#||||g|m||||||||||eng|| |
| 035 | __ | |a(IN-AhILN)th_445043 |
| 040 | __ | |aSAUR_360005|dIN-AhILN |
| 041 | __ | |aeng |
| 100 | __ | |aDate, Tushar Dilip|eResearcher |
| 110 | __ | |aDepartment of Pharmaceutics|bSaurashtra University, Rajkot|dMohali |
| 245 | __ | |aNanocarrier mediated Tumor specific Co-delivery of dual-action Cisplatin (IV) prodrug and venetoclax for improved Therapeutic outcomes in triple negative Breast Cancer treatment |
| 260 | __ | |aMohali|bSaurashtra University, Rajkot|c2022 |
| 502 | __ | |bPhD |
| 653 | __ | |aNanocarrier mediated |
| 653 | __ | |aTumor |
| 653 | __ | |aCisplatin (IV) prodrug |
| 653 | __ | |aTherapeutic outcomes |
| 653 | __ | |aBreast Cancer treatment |
| 700 | __ | |aJain, Sanyog|eGuide |
| 905 | __ | |anotification |
User Feedback Comes Under This section.